Search research articles
Contact Us
Filters
Showing results (61-70 of 70) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 70 results.
Nature Cancer
|
February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial
Aparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
JAMA Oncology
|
May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial
Janet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2014
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines
Margaret A Tempero, Mokenge P Malafa, Stephen W Behrman, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
Nature Medicine
|
November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Nature Medicine
|
September 11, 2019
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Nature Genetics
|
July 28, 2022
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L Hwang, Karthik A Jagadeesh, Jimmy A Guo, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 70) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 70 results.
Nature Cancer
|
February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial
Aparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2024
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
Ryan B Corcoran, Khanh T Do, Jeong E Kim, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2017
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, et al.
JAMA Oncology
|
May 31, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial
Janet E Murphy, Jennifer Y Wo, David P Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 8, 2014
Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines
Margaret A Tempero, Mokenge P Malafa, Stephen W Behrman, et al.
JCO Precision Oncology
|
September 2, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2021
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R Parikh, Emily E Van Seventer, Giulia Siravegna, et al.
Nature Medicine
|
November 21, 2019
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Nature Medicine
|
September 11, 2019
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, et al.
Nature Genetics
|
July 28, 2022
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment
William L Hwang, Karthik A Jagadeesh, Jimmy A Guo, et al.
Page
of 7